Insmed, Inc. (INSM)
112.58
+0.99
(+0.89%)
USD |
NASDAQ |
Oct 30, 16:00
112.65
+0.07
(+0.06%)
Pre-Market: 20:00
Insmed 30-Day Average Daily Volume : 3.301M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.301M |
| October 29, 2026 | 3.243M |
| October 28, 2026 | 2.922M |
| October 27, 2026 | 2.815M |
| October 26, 2026 | 2.815M |
| October 23, 2026 | 2.756M |
| October 22, 2026 | 2.699M |
| October 21, 2026 | 2.682M |
| October 20, 2026 | 2.678M |
| October 19, 2026 | 2.644M |
| October 16, 2026 | 2.614M |
| October 15, 2026 | 2.597M |
| October 14, 2026 | 2.552M |
| October 13, 2026 | 2.508M |
| October 12, 2026 | 2.515M |
| October 09, 2026 | 2.525M |
| October 08, 2026 | 2.478M |
| October 07, 2026 | 2.369M |
| October 06, 2026 | 2.342M |
| October 05, 2026 | 2.264M |
| October 02, 2026 | 2.122M |
| October 01, 2026 | 2.042M |
| September 30, 2026 | 2.004M |
| September 29, 2026 | 1.951M |
| September 28, 2026 | 1.959M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.966M |
| September 24, 2026 | 1.959M |
| September 23, 2026 | 1.937M |
| September 22, 2026 | 1.964M |
| September 21, 2026 | 2.005M |
| September 18, 2026 | 2.108M |
| September 17, 2026 | 2.394M |
| September 16, 2026 | 2.504M |
| September 15, 2026 | 2.599M |
| September 14, 2026 | 2.606M |
| September 11, 2026 | 2.649M |
| September 10, 2026 | 2.704M |
| September 09, 2026 | 2.691M |
| September 08, 2026 | 2.661M |
| September 04, 2026 | 2.671M |
| September 03, 2026 | 2.674M |
| September 02, 2026 | 2.670M |
| September 01, 2026 | 2.662M |
| August 31, 2026 | 2.697M |
| August 28, 2026 | 2.684M |
| August 27, 2026 | 2.685M |
| August 26, 2026 | 2.742M |
| August 25, 2026 | 2.746M |
| August 24, 2026 | 2.729M |
| August 21, 2026 | 2.778M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.928M |
| Vertex Pharmaceuticals, Inc. | 1.263M |
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| Incyte Corp. | 1.814M |
| United Therapeutics Corp. | 809792.5 |